These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35607965)

  • 1. LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis.
    Li C; Zhang L; Bu X; Chu G; Zhao X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):463-473. PubMed ID: 35607965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
    Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
    Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-30a-5p attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis by regulating PTEN protein expression and activating PI3K/Akt signaling pathway.
    Liang G; Guo C; Tang H; Zhang M
    BMC Cardiovasc Disord; 2024 May; 24(1):236. PubMed ID: 38705985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
    Chen T; Qin S; Gu Y; Pan H; Bian D
    Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis.
    Hu H; Wu J; Li D; Zhou J; Yu H; Ma L
    Biomed Pharmacother; 2018 Oct; 106():738-746. PubMed ID: 29990866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-383-3p protects cardiomyocytes against hypoxia/reoxygenation injury via regulating PTEN/PI3K/AKT signal pathway.
    Zeng H; Li Y; Liu X; Li X; Zhou T; Cao S; Wang M; Ju M
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23205. PubMed ID: 36224710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NORAD aggravates acute myocardial infarction by promoting fibrosis and apoptosis via miR-577/COBLL1 axis.
    Xiong X; Liu J; He Q; Dai R; Zhang H; Cao Z; Liao Y; Liu B; Zhou Y; Chen J; Liu J; Chen M
    Environ Toxicol; 2021 Nov; 36(11):2256-2265. PubMed ID: 34355838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOS1-IT1 silencing alleviates MPP
    Fan J; Wu D; Guo Y; Yang Z
    J Clin Neurosci; 2022 May; 99():137-146. PubMed ID: 35279586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
    Geng Q; Li Z; Li X; Wu Y; Chen N
    J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p.
    Fu T; Yang Y; Mu Z; Sun R; Li X; Dong J
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):680-692. PubMed ID: 34435542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p].
    Gao Y; Luo X; Liao P; Luo Y
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):479-486. PubMed ID: 37653011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-212-3p improves rat functional recovery and inhibits neurocyte apoptosis in spinal cord injury models via PTEN downregulation-mediated activation of AKT/mTOR pathway.
    Guan C; Luan L; Li J; Yang L
    Brain Res; 2021 Oct; 1768():147576. PubMed ID: 34216580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis.
    Liu W; Lin W; Yu L
    Bioengineered; 2022 Jan; 13(1):1424-1435. PubMed ID: 34978261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.